Close

Leerink Partners Downgrades Novartis (NVS) to Market Perform

March 23, 2016 6:27 AM EDT Send to a Friend
Leerink Partners downgraded Novartis (NYSE: NVS) from Outperform to Market Perform with a price target of $85.00 (from $98.00) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login